Crossref
Comparative Review of Denosumab Versus Zoledronic Acid for the Reduction or Delay of Serious Complications Associated with Bone Metastases of Breast Cancer
Clinical Medicine Reviews in Oncology · 2010
DOI: 10.4137/cmro.s3249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2010. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2010). Comparative Review of Denosumab Versus Zoledronic Acid for the Reduction or Delay of Serious Complications Associated with Bone Metastases of Breast Cancer. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s3249
Vancouver
Comparative Review of Denosumab Versus Zoledronic Acid for the Reduction or Delay of Serious Complications Associated with Bone Metastases of Breast Cancer. Clinical Medicine Reviews in Oncology. 2010. doi:10.4137/cmro.s3249
BibTeX
@article{euvimed2010,
title = {Comparative Review of Denosumab Versus Zoledronic Acid for the Reduction or Delay of Serious Complications Associated with Bone Metastases of Breast Cancer},
journal = {Clinical Medicine Reviews in Oncology},
year = {2010},
doi = {10.4137/cmro.s3249}
}
EUVIMED